Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 3-4/2013

01.02.2013 | main topic

Efficacy and safety of Echinaforce® in respiratory tract infections

verfasst von: PD Dr. med. Dr. h. c. Andreas Schapowal

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 3-4/2013

Einloggen, um Zugang zu erhalten

Summary

Echinaforce® is the standardised extract of Echinacea purpurea from Bioforce, Switzerland. Recent studies show immunomodulation and broad antiviral effects against respiratory tract viruses. Haemagglutinin and Neuraminidase are blocked. In contrast to Oseltamivir no resistance is caused by Echinaforce®. A randomised, double-blind, placebo-controlled study over four months confirms that Echinaforce® supports the immune resistance and acts directly against a series of viruses. Echinaforce® is efficacious and safe in respiratory tract infections for long-term and short-term prevention as well as for acute treatment.
Literatur
1.
Zurück zum Zitat Rotbart HA, Hayden FG. Picornavirus infections: a primer for the practitioner. Arch Fam Med. 2000;9(90):913–22.PubMedCrossRef Rotbart HA, Hayden FG. Picornavirus infections: a primer for the practitioner. Arch Fam Med. 2000;9(90):913–22.PubMedCrossRef
2.
Zurück zum Zitat Fendrick AM. Viral respiratory infections due to rhinoviruses: current knowledge, new developments. Am J Ther. 2003;10:193–202.PubMedCrossRef Fendrick AM. Viral respiratory infections due to rhinoviruses: current knowledge, new developments. Am J Ther. 2003;10:193–202.PubMedCrossRef
3.
Zurück zum Zitat Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey 1996. In: Vital and Health Statistics Series 10. Data from the National Health Survey; 1999. pp. 1–203. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey 1996. In: Vital and Health Statistics Series 10. Data from the National Health Survey; 1999. pp. 1–203.
4.
Zurück zum Zitat Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487–494.PubMedCrossRef Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487–494.PubMedCrossRef
5.
Zurück zum Zitat Johnston SL. Problems and prospects of developing effective therapy for common cold viruses. Trends Microbiol. 1997;5(2):58–63.PubMedCrossRef Johnston SL. Problems and prospects of developing effective therapy for common cold viruses. Trends Microbiol. 1997;5(2):58–63.PubMedCrossRef
6.
Zurück zum Zitat Jefferson T. Mistaken Identity: seasonal influenza versus influenza-like illness. Clin Evid. 2009;10:1-4. http://www. clinicalevidence.com/x/mce/file/05-10-09.pdf. Jefferson T. Mistaken Identity: seasonal influenza versus influenza-like illness. Clin Evid. 2009;10:1-4. http://​www.​ clinicalevidence.com/x/mce/file/05-10-09.pdf.
7.
Zurück zum Zitat Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ. 1995;310:1225–9.PubMedCrossRef Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ. 1995;310:1225–9.PubMedCrossRef
8.
Zurück zum Zitat Sharma M, Anderson SA, Schoop R, Hudson JB. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardised Echinacea, a potent antiviral herbal extract. Antiviral Res. 2009;83:165–70.PubMedCrossRef Sharma M, Anderson SA, Schoop R, Hudson JB. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardised Echinacea, a potent antiviral herbal extract. Antiviral Res. 2009;83:165–70.PubMedCrossRef
9.
Zurück zum Zitat Pleschka S, Stein M, Schoop R, et al. Anti-viral properties and mode of action of standardised Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J. 2009;6:197.PubMedCrossRef Pleschka S, Stein M, Schoop R, et al. Anti-viral properties and mode of action of standardised Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J. 2009;6:197.PubMedCrossRef
10.
Zurück zum Zitat Schapowal A. The triple action of the herbal medicine Echinaforce in the treatment of cold and flu-like infections. Swiss J Integr Med. 2011;23:1–5.CrossRef Schapowal A. The triple action of the herbal medicine Echinaforce in the treatment of cold and flu-like infections. Swiss J Integr Med. 2011;23:1–5.CrossRef
11.
Zurück zum Zitat Bonnet F, Lewden C, May T, et al. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis. 2005;37:482–7.PubMedCrossRef Bonnet F, Lewden C, May T, et al. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis. 2005;37:482–7.PubMedCrossRef
12.
Zurück zum Zitat Ritchie MR, Gertsch J, Klein P, et al. Effects of Echinaforce® treatment on ex vivo-stimulated blood cells. Phytomed. 2011;18(10):826–31.CrossRef Ritchie MR, Gertsch J, Klein P, et al. Effects of Echinaforce® treatment on ex vivo-stimulated blood cells. Phytomed. 2011;18(10):826–31.CrossRef
13.
Zurück zum Zitat Jawad M, Schoop R, Suter A, et al. Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med. 2012. doi:10.1155/2012/841315. Jawad M, Schoop R, Suter A, et al. Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med. 2012. doi:10.1155/2012/841315.
14.
Zurück zum Zitat Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. JHSB. 1983;24:385–96. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. JHSB. 1983;24:385–96.
Metadaten
Titel
Efficacy and safety of Echinaforce® in respiratory tract infections
verfasst von
PD Dr. med. Dr. h. c. Andreas Schapowal
Publikationsdatum
01.02.2013
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 3-4/2013
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-012-0166-0

Weitere Artikel der Ausgabe 3-4/2013

Wiener Medizinische Wochenschrift 3-4/2013 Zur Ausgabe